« Previous
Next »
Molecular Oncology
Volume 1, Issue 1
, Pages 55-71
, June 2007
Functional role of Meox2 during the epithelial cytostatic response to TGF-β
References
- . Regulation of Gax homeobox gene transcription by a combination of positive factors including myocyte-specific enhancer factor 2. Mol. Cell. Biol. 1995;15:4272–4281
- . p21WAF1/CIP1 mediates the growth response to TGF-β in human epithelial cells. Cancer Biol. Ther. 2004;3:221–225
- . Mox-1 and Mox-2 define a novel homeobox gene subfamily and are differentially expressed during early mesodermal patterning in mouse embryos. Development. 1992;116:1123–1136
- . The homeobox gene Gax activates p21WAF1/CIP1expression in vascular endothelial cells through direct interaction with upstream AT-rich sequences. J. Biol. Chem. 2007;282:507–517
- . Links between tumor suppressors: p53 is required for TGF-β gene responses by cooperating with Smads. Cell. 2003;113:301–314
- . Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA. 1995;92:5545–5549
- . Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 1995;270:28623–28628
- Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 1995;55:2910–2919
- . WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817–825
- . Inhibition of endothelial cell activation by the homeobox gene Gax. J. Surg. Res. 2003;111:91–99
- . Molecular cloning of a diverged homeobox gene that is rapidly down-regulated during the G0/G1 transition in vascular smooth muscle cells. Mol. Cell. Biol. 1993;13:3722–3733
- . Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 2005;17:548–558
- . Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF- β receptor activity. Mol. Cell. 2002;10:283–294
- . Analysis of Meox-2 mutant mice reveals a novel postfusion-based cleft palate. Dev Dyn. 2006;235:539–546
- . Id2 and Id3 define the potency of cell proliferation and differentiation responses to tranforming growth factor β and bone morphogenetic protein. Mol. Cell. Biol. 2004;24:4241–4254
- . Nuclear factor YY1 inhibits transforming growth factor β- and bone morphogenetic protein-induced cell differentiation. Mol. Cell. Biol. 2003;23:4494–4510
- . Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty. Cardiovasc. Res. 1997;35:536–546
- . Mox2 is a component of the genetic hierarchy controlling limb muscle development. Nature. 1999;400:69–73
- . How cells read TGF-β signals. Nat. Rev. Mol. Cell. Biol. 2000;1:169–178
- . G1 cell-cycle control and cancer. Nature. 2004;432:298–306
- . Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J. Biol. Chem. 2005;280:22115–22123
- . Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA. 1998;95:6733–6738
- . Mechanisms of TGF-β signaling in regulation of cell growth and differentiation. Immunol. Lett. 2002;82:85–91
- . Attenuation of the TGF-β-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-β-induced growth arrest. Oncogene. 2003;22:3698–3711
- . Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21WAF1/Cip1. J. Cell. Physiol. 2005;204:260–272
- . Role of Smad proteins and transcription factor Sp1 in p21Waf1/Cip1 regulation by transforming growth factor-β. J. Biol. Chem. 2000;275:29244–29256
- . Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer. Biochim. Biophys. Acta. 2007;1775:21–62
- . The homeobox gene Gax inhibits angiogenesis through inhibition of nuclear factor-κB-dependent endothelial cell gene expression. Cancer Res. 2005;65:1414–1424
- . Bax-mediated cell death by the Gax homeoprotein requires mitogen activation but is independent of cell cycle activity. EMBO J. 1998;17:3576–3586
- . The homeobox genes MSX2 and MOX2 are candidates for regulating epithelial–mesenchymal cell interactions in the human placenta. Placenta. 2000;21(Suppl. A):S50–S54
- . Meox homeodomain proteins are required for Bapx1 expression in the sclerotome and activate its transcription by direct binding to its promoter. Mol. Cell. Biol. 2004;24:2757–2766
- . Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p21WAF1/CIP1 but not p27KIP1. J. Biol. Chem. 2001;276:40687–40692
- . Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell. 2004;117:211–223
- . Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell. 2003;113:685–700
- . Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat. Rev. Cancer. 2003;3:807–820
- . Embryonic expression of the Gax homeodomain protein in cardiac, smooth, and skeletal muscle. Circ. Res. 1997;80:452–462
- . p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 1997;11:1674–1689
- . Regulation of cell proliferation by Smad proteins. J. Cell. Physiol. 2002;191:1–16
- . New insights into TGF-β-Smad signalling. Trends Biochem. Sci. 2004;29:265–273
- . Transforming growth factor-β employs HMGA2 to elicit epithelial–mesenchymal transition. J. Cell Biol. 2006;174:175–183
- . Functions of transforming growth factor-β family type I receptors and Smad proteins in the hypertrophic maturation and osteoblastic differentiation of chondrocytes. J. Biol. Chem. 2002;277:33545–33558
- . TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial–mesenchymal cell transition. Mol. Biol. Cell. 2005;16:1987–2002
- . Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor. J. Clin. Invest. 1999;104:1469–1480
- Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat. Med. 2005;11:959–965
PII: S1574-7891(07)00005-1
doi: 10.1016/j.molonc.2007.02.002
© 2007 Federation of European Biochemical Societies. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Molecular Oncology
Volume 1, Issue 1
, Pages 55-71
, June 2007

